Tag: molecular technology

PreciseType in WSJ

Post author By Zito Partners
Post date January 20, 2015
Categories In All News, Client News, Front Page (ZP)

Hospitals Aim to Better Match Blood Donors and Recipients New Risks to Patients Needing Transfusions As researchers uncover more genetic variations in blood types, they are identifying new risks to patients needing transfusions. Read the article here.

FDA panel recommends OK for Immucor test

Post author By Zito Partners
Post date March 18, 2014
Categories In All News, Client News, Front Page (ZP)

The U.S. Food and Drug Administration’s (FDA) Blood Products Advisory Committee voted to recommend approval of Immucor Inc.’s HEA Molecular BeadChip Test as a safe and effective evaluation for blood group typing. The test provides additional information about the composition of donor and patient blood, which may result in better matches for blood transfusion patients, […]